Evaluation of the Mutagenic Potential of Orlistat in Root Merymatic Cells of Allium cepa
Keywords:
obesity, genotoxicity, weight loss
Abstract
It has been manufactured constantly, more drugs against obesity, and a great part of these medicines can be bought without prescription, as is the case of Orlistat®. However, some drugs can cause genotoxic effects in the body, which are closely related to carcinogenesis and are therefore capable of cause DNA modifications and can cause great damage to cells. In order to provide information on safety for human health, thus contributing to public health, it is hoped to increase the knowledge about the genotoxic activity of the drug. Orlistat® to provide a broader picture of the possible side effects of this drug. For this, the Allium cepa test with different concentrations of Orlistat® was performed. It was found that the drug induced chromosomal aberrations in meristematic cells of onion root. Genotoxic assessment of medicinal products increases the complexity of assessing its side effects.
Downloads
- Article PDF
- TEI XML Kaleidoscope (download in zip)* (Beta by AI)
- Lens* NISO JATS XML (Beta by AI)
- HTML Kaleidoscope* (Beta by AI)
- DBK XML Kaleidoscope (download in zip)* (Beta by AI)
- LaTeX pdf Kaleidoscope* (Beta by AI)
- EPUB Kaleidoscope* (Beta by AI)
- MD Kaleidoscope* (Beta by AI)
- FO Kaleidoscope* (Beta by AI)
- BIB Kaleidoscope* (Beta by AI)
- LaTeX Kaleidoscope* (Beta by AI)
How to Cite
References
J. Amatruda, S. Welle (1995) Obesity.
G. Brambilla, F. Mattioli, L. Robbiano, A. Martelli (2011) Studies on genotoxicity and carcinogenicity of antibacterial, antiviral, antimalarial and antifungal drugs. 1-27.
Giovanni Brambilla, Francesca Mattioli, Luigi Robbiano, Antonietta Martelli (2012) Update of carcinogenicity studies in animals and humans of 535 marketed pharmaceuticals. 750(1), 1-51. https://doi.org/10.1016/j.mrrev.2011.09.002
M. Chakrabart, I. Ghosh, A. Jana, M. Ghosh, A. Mukherjee (2016) Genotoxicity of antiobesity drug orlista and effect of caffeine intervention: an in vitro study. 1-5.
C. Cuchiara, C. Borges, V. Bobrowski (2012) Sistema teste de Allium cepa como bioindicador da citogenotoxicidade de cursos d'água. 6, 33-38.
M. Dias (2014) Efeito genotóxico e antiproliferativo de Mikania cordifolia (L. F.) Willd. (Asteraceae) sobre o ciclo celular de Allium cepa L. 16(2), 202-208.
M. Drent (1993) Lipase inhibition: a novel concept in the treatment of obesity. 17, 241-244.
M. Drent (1995) et al., 1995 Orlistat (RO 18-0647), a lipase inhibitor , in the treatment of human obesity : a multiple dose study. 19, 221-226.
R. Fortes, N. Guimarães, A. Haack, A. Torres, K. Carvalho (2006) Orlistat e sibutramina: bons coadjuvantes para perda e manutenção de peso? Rev Bras Nutr. 21, 244-251.
A. Guyton, J. Hall (1997) Tratado de fisiologia médica.
A. Halpern, M. Mancini (1999) Obesidade. 1, 58-65.
Halpern, A.; Monegaglia, A. A.P.; Oliva (2000) Beyruti, M.; Halpern, Z.S.C.; Mncini, M.C., 2000 Experiência clínica com o uso conjunto de Sibutramina e Orlistat em pacientes obesos. 44(1), 103-105.
W. James (1997) et al., 1997 A one -year trial to asses the value of orlistat in the management of obesity. 21, 24-30.
R. Kruger (2009) Análise da toxicidade e da genotoxicidade de agrotóxicos utilizados na agricultura utilizando bioensaios com Allium cepa.
E. Lopes, V. Vicentini (2002) Avaliação da mutagenicidade do Xenical (Orlistat) utilizando-se células da medula óssea de ratos Wistar, em tratamento agudo, via gavagem.
J. Menendez, L. Vellon, R. Lupu (2005) Antitumoral actions of the anti-obesity drug orlistat (Xenical) in breast cancer cells: blockade of cell cycle progression, promotion of apoptotic cell death and PEA3-mediated transcriptional repression of Her2/neu(erb B-2) oncogene. 16(8), 1253-1267. https://doi.org/10.1093/annonc/mdi239
P. Orsolin, R. Silva-Oliveira, J. Nepomuceno (2012) Assessment of the mutagenic, recombinagenic and carcinogenic potential of orlistat in somatic cells of Drosophila melanogaster. 50(8), 2598-2604. https://doi.org/10.1016/j.fct.2012.05.008
F. Pi-Sunyer (1997) Obesity.
B. Popkin (2007) Global context of obesity. 227-238.
R. Radominski (2010) Atualização das diretrizes para o tratamento farmacológico da obesidade e do sobrepeso.
Jette Rank, Mette Nielsen (1993) A Modified Allium Test as a Tool in the Screening of the Genotoxicity of Complex Mixtures. 118(1), 49-53. https://doi.org/10.1111/j.1601-5223.1993.t01-3-00049.x
C. Ribeiro, H. Reis Filho, S. Grotzner (2012) Ribeiro, C.A.O.; Reis Filho, H.S.; Grotzner, S.R., 2012. Técnicas e Métodos para Utilização Prática Figures de Microscopia. São Paulo: GEN - Grupo Editorial Nacional. 1, 440.
J. Zhi (1994) et al., 1994 Retrospective population based analysis of the dose response (fecal fat excretion) relationship of orlistat in normal and obese volunteers. 56(1), 82-85. https://doi.org/10.1038/clpt.1994.104
J. Zhi (1995) Review of Limited Systemic Absorption of Orlistat, a Lipase Inhibitor, in Healthy Human Volunteers. 35(11), 1103-1108. https://doi.org/10.1002/j.1552-4604.1995.tb04034.x
Published
2017-04-11
Issue
Section
License
Copyright (c) 2017 Authors and Global Journals Private Limited

This work is licensed under a Creative Commons Attribution 4.0 International License.